Navigation Links
Agendia Welcomes Dr. Mark Gittleman to Expanding Medical Advisory Board
Date:7/10/2012

IRVINE, Calif. and AMSTERDAM, July 10, 2012 /PRNewswire/ -- Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced that Dr. Mark Gittleman, Medical Director of Breast Care Specialists and Advanced Breast Care Imaging, has joined the company's Medical Advisory Board. The board will play a key role in advising Agendia on the clinical application of its extensive product pipeline, including its Symphony suite of tests for breast cancer and its ColoPrint test for colon cancer.

(Photo: http://photos.prnewswire.com/prnh/20120710/NY37010 )

"I have been impressed by the science and methodologies behind Agendia's product development, the conversion of their tests to an FFPE format and the numerous validation studies that have been published to date," said Dr. Gittleman. "These tests have been extremely useful in appropriately directing targeted systemic therapy for my breast cancer patients. For these reasons, I am pleased to have been asked to join Agendia's Medical Advisory Board, and I look forward to contributing and sharing new ideas to reach our common goals."

As a breast cancer specialist, Dr. Gittleman has a vested interest in new technologies that enable medical professionals to better understand the biology of breast cancer, thereby helping patients attain better outcomes through the application of validated, clinically useful technologies such as Agendia's MammaPrint, BluePrint, TargetPrint and TheraPrint gene profiling tests. He is a past president of the American Society of Breast Surgeons. Dr. Gittleman currently serves on the ASBS Coding and Reimbursement and Breast Imaging Technology committees and is a reviewer for Ultrasound and Stereotactic certification applicants.

"With his vast knowledge and experience in breast imaging and minimally invasive biopsy techniques, Dr. Gittleman brings a unique perspective to our growing Medical Advisory Board," said David Macdonald, CEO of Agendia. "As Agendia invests significantly in clinical research studies to support the use of new diagnostic tests, our Medical Advisory Board will be an integral part of our clinical trial development. We look forward to working with Dr. Gittleman in our efforts to advance the future of healthcare and bring personalized medicine to breast and colon cancer patients."

About Agendia:

Agendia is a leading molecular diagnostic company that develops and markets genomic-based diagnostic products, which help support physicians with their complex treatment decisions. Agendia's breast cancer Symphony™ suite was developed using unbiased gene selection, analyzing the complete human genome, ensuring 100% definitive results for cancer patients.  Symphony includes MammaPrint, the first and only FDA-cleared IVDMIA breast cancer recurrence assay, as well as BluePrint­­, a molecular subtyping assay, TargetPrint®, an ER/PR/HER2 expression assay, and TheraPrint®, an alternative therapy selection assay. Together, these tests help physicians determine a patient's individual risk for metastasis, which patients will benefit from chemo, hormonal, or combination therapy, and which patients do not require these treatments and can instead be treated with other less arduous and less costly methods.

In addition to the Symphony suite of tests, Agendia has a rich pipeline of genomic products in development. The company collaborates with pharmaceutical companies, leading cancer centers and academic groups to develop companion diagnostic tests in the area of oncology and is a critical partner in the ISPY-2 and MINDACT trials.

For more information, please visit www.agendia.com.

For further information, please contact: Post+Beam Melissa Hurley Tel: +1 646 442 2773 E-mail: hurley@postandbeam.is

 

 


'/>"/>
SOURCE Agendia
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
2. Agendia Signs Contract with Blue Shield of California
3. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
4. The 14th Annual LOréal-Unesco Awards or Women on Science: From March 26 to March 29, Paris Welcomes and Honours Tomorrows Scientific Talents
5. Cepheid Welcomes Senior Vice President of Human Resources
6. Study suggests expanding the genetic alphabet may be easier than previously thought
7. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
8. Medical Marijuana Inc. Shareholder Update - PhytoSPHERE Systems, LLC
9. Medi-Solve Coatings Develops Masking Process for Medical Devices
10. San Diego Medical Director Wins Two Book Awards For Latest Medical Thriller
11. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... ... Cambridge Semantics, the leading provider of Smart Data analytic and data ... to The Silicon Review’s “20 Fastest Growing Big Data Companies of 2016.” , ... of end users facing some of the most complex data challenges in the industry,” ...
(Date:4/27/2016)... ... ... The Pittcon Organizing Committee is pleased to announce that Charles “Chuck” Gardner was ... since 1987. Since then, he has served in a number of key leadership positions ... the program and exposition committees. In his professional career, Dr. Gardner is the director ...
(Date:4/27/2016)... , April 27, 2016 ... (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... an ihre Pressemitteilung vom 13. August 2015 die ... ihre Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 ... Dollar zu bringen. Davon wurden 157.900.000 Einheiten mit ...
(Date:4/27/2016)... Islands (PRWEB) , ... April 27, 2016 , ... ... Ltd. (d/b/a Biohaven) is pleased to announce the appointment of John Tilton as Chief ... an Executive Director and one of the founding commercial leaders responsible for the ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
Breaking Biology News(10 mins):